Jefferies & Co. downgrades Genentech (NYSE: DNA) from Buy to Hold.

Despite huge action in the pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE